Meeder Asset Management’s BioTelemetry, Inc. BEAT Stock Holding History

Meeder Asset Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-44	Closed	-$3K	–	2535
2020 Q4	$3K	Buy	44 +2	+5%	+$105	﹤0.01%	1429
2020 Q3	$2K	Buy	42 +2	+5%	+$84	﹤0.01%	1902
2020 Q2	$2K	Buy	40 +31	+344%	+$1.39K	﹤0.01%	1842
2020 Q1	$0	Buy	+9	New	+$414	﹤0.01%	2679
2019 Q2	–	Sell	-2,491	Closed	-$154K	–	2246
2019 Q1	$154K	Buy	2,491 +714	+40%	+$49K	0.01%	599
2018 Q4	$108K	Buy	+1,777	New	+$107K	0.01%	625
2017 Q4	–	Sell	-1,519	Closed	-$50K	–	1923
2017 Q3	$50K	Buy	1,519 +98	+7%	+$3.39K	0.01%	686
2017 Q2	$48K	Buy	+1,421	New	+$42.4K	﹤0.01%	685
2016 Q2	–	Sell	-24,086	Closed	-$281K	–	1009
2016 Q1	$281K	Sell	24,086 -9,074	-27%	-$101K	0.03%	523
2015 Q4	$387K	Buy	33,160 +3,057	+10%	+$38.7K	0.03%	418
2015 Q3	$368K	Buy	+30,103	New	+$384K	0.04%	434

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Meeder Asset Management's BEAT Position: Q1 2021 in Review

Meeder Asset Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 44 shares — an estimated $3K sold.

Meeder Asset Management first reported a position in BEAT in Q3 2015 and held it in 11 quarters. The position peaked at $387K in Q4 2015. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Meeder Asset Management reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Meeder Asset Management sold 44 BioTelemetry, Inc. shares in Q1 2021, an estimated $3K.
Meeder Asset Management first reported a position in BioTelemetry, Inc. in Q3 2015 and held it in 11 quarters.
Meeder Asset Management's BioTelemetry, Inc. position peaked at $387K in Q4 2015.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Meeder Asset Management's 13F filing for Q1 2021, filed 28 Apr 2021.